thalidomide has been researched along with hydroxychloroquine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 3 (27.27) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
McCune, WJ; Singer, NG | 1 |
Ayoub, N; Barete, S; Francès, C; Piette, JC | 1 |
Deng, YJ; Hao, F; Liu, RQ; Sun, RS; Wang, JW; Xiang, MM; Ye, QY; Zhong, BY; Zhou, CL | 1 |
Beylot-Barry, M; Doutre, MS; Pham-Ledard, A; Vergier, B | 1 |
Bayliss, SJ; Berk, DR; Lu, D; Miller, A; Scarlett, D; Wippold, FJ | 1 |
Garza-Mayers, AC; McClurkin, M; Smith, GP | 1 |
Tran, B; Wu, J; Yazdani Abyaneh, MA | 1 |
Chen, PH; Huang, KP; Lin, CH; Lin, CY; Ni, YL; Tung, HH | 1 |
He, J; Liu, T; Xiao, X; Zhou, W | 1 |
3 review(s) available for thalidomide and hydroxychloroquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide | 1998 |
Review of treatment for discoid lupus erythematosus.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Dapsone; Humans; Hydroxychloroquine; Laser Therapy; Lupus Erythematosus, Discoid; Methotrexate; Phototherapy; Retinoids; Smoking Cessation; Thalidomide | 2016 |
8 other study(ies) available for thalidomide and hydroxychloroquine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[Classification of dermatologic manifestations in lupus erythematosus].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Combinations; Female; Glucosamine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Infant, Newborn; Isotretinoin; Keratolytic Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Male; Middle Aged; Skin; Sulfasalazine; Thalidomide; Thrombosis; Ultraviolet Therapy; Vasculitis | 2003 |
Generalized eruptive histiocytosis: a possible therapeutic cure?
Topics: Adult; Dermatologic Agents; Drug Therapy, Combination; Facial Dermatoses; Histiocytosis, Langerhans-Cell; Humans; Hydroxychloroquine; Male; Prednisone; Thalidomide | 2004 |
Disseminated cutaneous lymphoid hyperplasia of 12 years' duration triggered by vaccination.
Topics: Adolescent; B-Lymphocytes; CD3 Complex; Cyclins; DNA-Binding Proteins; Female; Hepatitis B Vaccines; Humans; Hydroxychloroquine; Neprilysin; Proto-Oncogene Proteins c-bcl-6; Pseudolymphoma; Skin Neoplasms; T-Lymphocytes; Thalidomide; Vaccination | 2010 |
Osseous metaplasia late in the course of nephrogenic systemic fibrosis.
Topics: Adult; Analgesics; Calcinosis; Disease Progression; Female; gamma-Aminobutyric Acid; Humans; Hydroxychloroquine; Kidney Failure, Chronic; Kidney Transplantation; Lupus Erythematosus, Systemic; Metaplasia; Nephrogenic Fibrosing Dermopathy; Pregabalin; Quinacrine; Skin; Thalidomide; Treatment Outcome | 2010 |
Rapid response to treatment with thalidomide in an adolescent with generalized discoid lupus erythematosus.
Topics: Adolescent; Anti-Inflammatory Agents; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Male; Thalidomide | 2020 |
A case report of secondary synchronous diagnosis of multiple myeloma and systemic lupus erythematosus after breast cancer treatment: A CARE-compliant article.
Topics: Aged; Antibodies, Monoclonal; Breast Neoplasms; Female; Glycoproteins; Humans; Hydrocortisone; Hydroxychloroquine; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Multiple Myeloma; Thalidomide | 2022 |
Refractory Behçet's disease treated with low-dose interleukin-2: A case report.
Topics: Adult; Behcet Syndrome; Erythema Nodosum; Female; Humans; Hydroxychloroquine; Interleukin-2; Methylprednisolone; Oral Ulcer; Thalidomide | 2022 |